“…Toxicity of lipid formulations was also shown to depend on particle size and lamellarity [40] , [41] , [42] , [43] , on the nature of and relative concentration of the sterol(s), and the drug-to-lipid ratios [44] , [45] , [46] . Studies on these parameters involved in vivo studies (mice or rats), in vitro cell lines [47 , 48] and surrogate toxicity testing systems like potassium release in erythrocytes [28 , 49] , or artificial system models for toxicity [15 , 50] . While the effects of the lipids on toxicity may be partially derived from influencing the equilibria amongst different aggregate forms in the liposomes, this could also be related to liposome-cell (membrane), liposome-lipoprotein, and liposome-albumin interactions in vivo (affecting pharmacodynamics and pharmacokinetics).…”